NASH is a common liver diseases characterized by fatty liver, in which TLR9 plays a pathogenic role in driving inflammatory response by responding to mtDNA released from damaged hepatocytes [49]. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.